2016
DOI: 10.1007/s00345-016-1836-0
|View full text |Cite
|
Sign up to set email alerts
|

Are you now a good surgeon? T2 positive margin status as a quality outcome measure following radical prostatectomy

Abstract: ObjectiveTo assess potential biases, such as the reporting pathologist, that may affect objectivity of T2 positive margin rates as a quality outcome measure following radical prostatectomy.Patients and methodsProspective data on 183 consecutive LRP patients with pT2 disease, operated on by a single surgeon (2003–2009), were studied. Outcomes were grouped as pre-, peri-, and post-operative and included: age, ethnicity, Gleason score, reporting pathologist, percentage of positive cores, operative time, blood los… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
5
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 29 publications
(37 reference statements)
0
5
0
Order By: Relevance
“…It helps accelerate evidence generation through providing observational studies that can generate new hypotheses and support policy makers. Prior to its formal development, a wide variety of studies had already been published using the clinical data of GSTT's cancer patients (based on individual ethics or audit approval) including various studies focused on prostate cancer [4][5][6][7][8][9], breast cancer [10][11][12][13] and renal cancer [14]. The below case study shows how data from Guy's Cancer Cohort was used to address a clinically important question for bladder cancer:…”
Section: Utility and Discussionmentioning
confidence: 99%
“…It helps accelerate evidence generation through providing observational studies that can generate new hypotheses and support policy makers. Prior to its formal development, a wide variety of studies had already been published using the clinical data of GSTT's cancer patients (based on individual ethics or audit approval) including various studies focused on prostate cancer [4][5][6][7][8][9], breast cancer [10][11][12][13] and renal cancer [14]. The below case study shows how data from Guy's Cancer Cohort was used to address a clinically important question for bladder cancer:…”
Section: Utility and Discussionmentioning
confidence: 99%
“…For the total cohort of 530 patients, PSMs were observed in 156 (29%) patients, of which 18 had two or more PSMs. The incidence of PSMs reported in recent radical prostatectomy series varies widely (12–35%) [3–6, 8, 14, 1618, 29], partly due to the large inter-observer variability in identifying PSMs [28], and is also related to surgical experience [3, 6, 9, 12, 13]. For instance, in their study of 1701 RALPs, Sivaraman et al [6] described a sharp decrease of PSM incidence from 25 to 20% after the first 350 patients.…”
Section: Discussionmentioning
confidence: 99%
“…However, as expected, maximal NVB sparing was related to an increased risk of surgical margin positivity. In this study, the rate of positive surgical margin was higher than in previous reports, which might come from the inclusion of patients with intermediate risk disease [ 22 ]. However, even considering this fact, the proportion of ≥pathologic T3a disease and pathologic Gleason score ≥7 thought to be high, which may be attributed to the aggressive features of prostate cancer in Asian men [ 23 ].…”
Section: Discussionmentioning
confidence: 56%